Platform
Features
Pricing
0 followers
Trishula Therapeutics is a clinical-stage cancer immunotherapy company developing TTX-030, a first-in-class anti-CD39 antibody.
Industries
Headquarters
Employees
Links
Anil Singhal
2 members
3 members
BeiGene
19 followers
Immunome
2 followers
Abbott
277 followers
Thermo Fisher Scientific
156 followers
Biogen
114 followers
Alexion Pharmaceuticals
34 followers
Cytiva
10 followers
Ascendis Pharma
8 followers
NeoGenomics
NBOUND
Pendulum
4 followers
Explore companies